BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.83%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.15B
AUM Growth
+$6.15B
(-6.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-4.53%
Top 10 Holdings %
Top 10 Hldgs %
39.96%
Holding
178
New
9
Increased
65
Reduced
60
Closed
12
Top Buys
| 1 |
Stryker
SYK
|
$32.9M |
| 2 |
Biohaven
BHVN
|
$30.9M |
| 3 |
UnitedHealth
UNH
|
$29M |
| 4 |
Insulet
PODD
|
$28.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$26.5M |
Top Sells
| 1 |
Insmed
INSM
|
$75M |
| 2 |
Intuitive Surgical
ISRG
|
$63.3M |
| 3 |
argenx
ARGX
|
$51.2M |
| 4 |
Boston Scientific
BSX
|
$44.6M |
| 5 |
Humana
HUM
|
$40M |
Sector Composition
| 1 | Healthcare | 99.91% |
| 2 | Industrials | 0.05% |
| 3 | Communication Services | 0.02% |
| 4 | Technology | 0.02% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CareDx
CDNA
$678M
| $60.8M | 0.99% |
3,912,575
-21,431
| -0.5% | -$333K |
|
27
Elevance Health
ELV
$72.4B
| $55M | 0.89% |
101,549
+2,937
| +3% | +$1.59M |
|
28
Penumbra
PEN
$10.5B
| $50.8M | 0.82% |
282,049
+100,891
| +56% | +$18.2M |
|
29
Exact Sciences
EXAS
$9.33B
| $49M | 0.8% |
1,158,880
+20,354
| +2% | +$860K |
|
30
Zimmer Biomet
ZBH
$20.8B
| $48.7M | 0.79% |
449,081
+166,864
| +59% | +$18.1M |
|
|
SAGE
31
DELISTED
Sage Therapeutics
SAGE
| $48.5M | 0.79% |
4,464,693
-851
| -0% | -$9.24K |
|
32
Charles River Laboratories
CRL
$7.99B
| $48.1M | 0.78% |
232,702
+3,005
| +1% | +$621K |
|
33
Idexx Laboratories
IDXX
$50.7B
| $45.5M | 0.74% |
93,358
| – | – |
|
34
Eli Lilly
LLY
$661B
| $45M | 0.73% |
49,674
-8,291
| -14% | -$7.51M |
|
35
Bio-Rad Laboratories Class A
BIO
$7.8B
| $42.4M | 0.69% |
155,258
-1,360
| -0.9% | -$371K |
|
36
MacroGenics
MGNX
$121M
| $42.3M | 0.69% |
9,942,313
-23,549
| -0.2% | -$100K |
|
37
Axsome Therapeutics
AXSM
$6.09B
| $41.6M | 0.68% |
516,533
-168,943
| -25% | -$13.6M |
|
38
Relay Therapeutics
RLAY
$709M
| $41.6M | 0.68% |
6,377,115
+450,497
| +8% | +$2.94M |
|
39
ESSA Pharma
EPIX
$11.2M
| $41.5M | 0.67% |
7,889,583
| – | – |
|
40
Procept Biorobotics
PRCT
$2.11B
| $40.9M | 0.66% |
669,049
-221,065
| -25% | -$13.5M |
|
41
Cigna
CI
$80.2B
| $40.7M | 0.66% |
123,090
+43,445
| +55% | +$14.4M |
|
42
GE HealthCare
GEHC
$33B
| $40.6M | 0.66% |
521,017
+8,787
| +2% | +$685K |
|
43
Exelixis
EXEL
$9.95B
| $40.5M | 0.66% |
1,803,200
-100,000
| -5% | -$2.25M |
|
44
Sarepta Therapeutics
SRPT
$1.98B
| $39.9M | 0.65% |
252,321
+800
| +0.3% | +$126K |
|
45
Black Diamond Therapeutics
BDTX
$164M
| $39.7M | 0.65% |
8,517,839
| – | – |
|
46
HCA Healthcare
HCA
$95.4B
| $39.3M | 0.64% |
122,304
-37,399
| -23% | -$12M |
|
47
Option Care Health
OPCH
$4.7B
| $39.2M | 0.64% |
1,416,879
-450,384
| -24% | -$12.5M |
|
48
Immunocore
IMCR
$1.78B
| $39.1M | 0.64% |
1,154,654
+182,400
| +19% | +$6.18M |
|
49
Align Technology
ALGN
$9.59B
| $34.8M | 0.56% |
143,982
-10,927
| -7% | -$2.64M |
|
50
Cooper Companies
COO
$13.3B
| $34.7M | 0.56% |
397,373
| – | – |
|